Momentum Stocks

NUS @ $19.55 (Nu Skin Enterprise) is a network marketer of personal care products and nutritional supplements under the Nu Skin and Pharmanex brands. Earnings are expected to grow 38% this year and another 13% in 2009 to $1.36 a share. Institutional sponsorship has steadily increased over the last year and volume has steadily risen over the last month. The stock has closed higher during 15 of the last 18 days, as it's climbed from the $16 level. We will establish half a position here and enter the remaining half on a pull back to $17.50. Our stop loss will be set at $16.50. 

IPO's and New Issues

V @ $37-$42 (Visa) which we discussed a couple of weeks ago is going to price their offering tomorrow and begin trading on Wednesday. If they price this offering in between $37 and $42 tomorrow, we will look to get involved with at least half a position on Wednesday at any price under $45 and will then re-evaluate after the initial euphoria subsides. Hopefully, anyone that has had the ability to get involved with the IPO has taken advantage of it.

Foreign Stocks

AUO @ $18.18 (A U Optronics) is a Taiwanese manufacturer of flat panel displays for desktop and notebook computers, LCD TV's and consumer electronics. For our more aggressive traders, we are establishing a position here and will set our stop loss at $17.50. Our investors could establish half a position here and enter the remaining half on a pull back to $16. Our stop loss will be set at a move below $15.20.

HSVLY @ $20.56 (Highveld Steel and Vanadium) is a South African manufacturer of Vanadium for the steel industry with interests in other metals. This stock is thinly traded and limit orders need to be used when purchasing. We will establish 1/4 of a position here and enter the second 1/4 at $19. The remaining half will be bought on our first pull back to its rising 50 day moving average and our stop will be 0.50 cents below that level, currently $16.

This newsletter has been sent to you for informative purposes only and in no event should be construed as a representation by The Stock Playbook or its employees as an offer to sell or solicitation of an offer to buy any securities. The factual information given is taken from sources we believe to be reliable, but is not guaranteed as to its accuracy or completeness. The opinions expressed should be given only such weight as opinions warrant.  employees and/or family members may have a position in the securities mentioned and may make purchase and/or sales of such securities from time to time in the open market or otherwise Recipients of The Stock Playbook prohibited from, directly or indirectly, distributing, forwarding , plagiarizing or copying any part of this message without expressed written consent from The Stock Playbook. Some content may have been based, at least in part, on material gathered from Investor's Business Daily ® and/or YAHOO!®